-
61. The impact of obesity and the effect of type of assessment on AVF survival in patients on hemodialysis
I. Griveas, et al. Nephrology Department 417 NIMTS, Athens.
1st International Diabetes and Obesity Forum, Athens 21-23 October 2010.
-
62. ADPKD: Who needs hospital follow up?
I Griveas, K. Bishop, MJ World.
Nephrology Department Queen Elizabeth Hospital, Birmingham, UK.
British Renal Society Conference, Birmingham 6-9 June 2011.
-
63. Ιnterventional Nephrology: placement of tunnelled central line under ultrasound guidance in "real time"
I. Griveas, J.O.Nwosu.
Nephrology Department Queen Elizabeth Hospital, Birmingham, UK.
10th BANTAO CONGRESS, Chalkidiki, 13-15/2/2011.
-
64. Ιnterventional Nephrology: native and transplant kidney biopsy under ultrasound guidance in “real time”
I. Griveas, J.O.Nwosu.
10th BANTAO CONGRESS, Chalkidiki, 13-15/2/2011.
British Renal Society Conference, Birmingham 6-9 June 2011.
-
65. Ιnterventional Nephrology: peritoneal dialysis catheter insertion with peritoneoscopic technique
I. Griveas, J.O.Nwosu.
Nephrology Department Queen Elizabeth Hospital, Birmingham, UK.
10th BANTAO CONGRESS, Chalkidiki, 13-15/2/2011.
-
66. Serum creatinine (2 mg/dl) sensitivity is not adequate to predict adverse outcomes following very severe peripheral vascular surgery
D. Koumoutsea, V. Tsiligiris, S. Kalakonas, E. Chouliaras, I. Griveas, A. Galinas, A. Salapata, I. Angelakas, G. Stavianoudakis, K. Karamitsos
10th BANTAO CONGRESS, Chalkidiki, 13-15/2/2011.
-
67. HEAT-SHOCK PROTEIN 27 KINETICS IN END STAGE RENAL DISEASE
I. Griveas1, P. PASSADAKIS1
1NEPHROLOGY, 401 ARMY HOSPITAL OF ATHENS, GREECE, ATHENS, Greece.
THE RENAL ASSOCIATION CONFERENCE 2012, 12-14 June 2012 THE SAGE GATESHEAD, Newcastle, UK.
-
68. Treatment with tacrolimus or cyclosporine A in patients with idiopathic nephrotic syndrome
Ioannis Griveas.
11th BANTAO CONGRESS, Timisoara, Romania, 26-29/9/2013.
-
69. Chronic Kidney Disease: from primary to secondary care
Ioannis Griveas.
11th BANTAO CONGRESS, Timisoara, Romania, 26-29/9/2013.
-
70. Correlation of abdominal aortic calcification with cardiac hypertrophy, pulse pressure and mineral and bone disease biochemistries in hemodilaysis patients
D. Bacharaki, I. Griveas, K. Stamatelou, P. Sitaras.
52nd ERA-EDTA, London 28-31 May 2015 British Renal Society Annual Conference, 30th Hune-2nd July 2015, Leeds, UK.
-
71. Soluble Urokinase Plasminogen Receptor (SUPAR): A future risk marker foe hemodialysis patients?
I. Griveas, C. Andriopoulos, P. Sitaras, M. Aktsiali.
52nd ERA-EDTA, London 28-31 May 2015 and British Renal Society Annual Conference, 30th Hune-2nd July 2015, Leeds, UK.
-
72. EFFECT OF ORAL ORAL SUCROSOMIAL IRON IN CKD PATIENTS WITH ANEMIA
I. Griveas.
4th Mediterranean Multidisciplinary Course on Iron Anemia April 29th–30th 2016, Madrid, Spain.
-
73. CLINICAL EXPERIENCE WITH ORAL SUCROSOMIAL IRON IN A SEVERE ANEMIC PATIENT WITH CHRONIC KIDNEY DISEASE
I. Griveas.
4th Mediterranean Multidisciplinary Course on Iron Anemia April 29th–30th 2016, Madrid, Spain.
-
74. Εffect of citrate based on anticoagulation therapy in maintenance haemodialysis patients
I. Griveas.
53rd ERA-EDTA, Vienna 21-24 May 2016.
-
75. Abdominal Aortic Calicifications as a Prognostic Factor of All CauseMortality in Hemodialysis Patients
Kyriaki Stamatelou,1 Dimitra Bacharaki,2 Ioannis Griveas,3 John Kyriazis,4 Dimitrios V. Vlahakos.2 .
1Nephrology, Galinos Hospital, Athens, Greece;
2Nephrology, Atticon Hospital, Chaidari, Greece;
3Dialysis, NEFROIATRIKI, Athens, Greece; 4Nephrology, General Hospital, Chios, Greece.
ASN-Renal week , Chicago 15-20 November 2016.
